LABT (LABT)
1.88
-0.02 (1.05%)
Upcoming Events
Latest Headlines
Form 424B3 Lakewood-Amedex Biothera
August 17, 2026 4:45 PM - SEC Filing
Form SCHEDULE 13G Lakewood-Amedex Biothera Filed by: WFI Equity, LLC
August 14, 2026 4:22 PM - SEC Filing
Form 10-Q Lakewood-Amedex Biothera For: Jun 30
August 14, 2026 6:12 AM - SEC Filing
Form DEFA14A Lakewood-Amedex Biothera
August 10, 2026 5:15 PM - SEC Filing
Form DEF 14A Lakewood-Amedex Biothera For: Sep 22
August 10, 2026 5:14 PM - SEC Filing
Form SCHEDULE 13G Lakewood-Amedex Biothera Filed by: Lindesfarne LLC
August 6, 2026 2:19 PM - SEC Filing
Form PRE 14A Lakewood-Amedex Biothera For: Jul 30
July 30, 2026 4:31 PM - SEC Filing
Lakewood-Amedex shares resistance data for antibiotic candidate Nu-3
July 22, 2026 8:03 AM - StreetInsider
Lakewood-Amedex Biotherapeutics Highlights Nu-3 Resistance Data in Response to National Action Plan of Presidential Advisory Council on Combating Antibiotic Resistant Bacteria
July 22, 2026 8:02 AM - PR NewsWire
Form 8-K Lakewood-Amedex Biothera For: Jul 15
July 15, 2026 4:16 PM - SEC Filing
Lakewood-Amedex reports preclinical safety data for Nu-3 gel trial
July 15, 2026 8:02 AM - StreetInsider
Lakewood-Amedex Biotherapeutics Announces Preclinical Safety Data Supporting Clinical Dose Selection for Upcoming Phase 2a Trial of Nu-3 Gel
July 15, 2026 8:02 AM - PR NewsWire
Lakewood-Amedex backs PASTEUR Act, plans Phase 2 trial for Nu-3
July 7, 2026 8:03 AM - StreetInsider
Lakewood-Amedex Biotherapeutics Supports Reintroduction of the PASTEUR Act and Focus on Combating Antimicrobial Resistance
July 7, 2026 8:02 AM - PR NewsWire
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
June 26, 2026 8:35 AM - StreetInsider
Lakewood-Amedex names USC professor to chair diabetic foot ulcer trial
June 25, 2026 8:02 AM - StreetInsider
Lakewood-Amedex Biotherapeutics Announces World-Renowned Expert David G. Armstrong, M.D., Ph.D., as Study Chair for Phase 2a Trial of Nu-3 in Infected Diabetic Foot Ulcers
June 25, 2026 8:02 AM - PR NewsWire
Form SCHEDULE 13G Lakewood-Amedex Biothera Filed by: HPW Investments Holding Ltd.
June 23, 2026 11:10 AM - SEC Filing
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
June 23, 2026 8:35 AM - Globe NewsWire
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
June 23, 2026 8:35 AM - StreetInsider
Form 424B3 Lakewood-Amedex Biothera
June 22, 2026 4:12 PM - SEC Filing
Form 424B3 Lakewood-Amedex Biothera
June 22, 2026 4:11 PM - SEC Filing
Lakewood-Amedex receives Australian patent for antimicrobial compounds
June 22, 2026 8:04 AM - StreetInsider
Lakewood-Amedex Biotherapeutics Secures Composition of Matter Patent Protecting New Bisphosphocin® Compounds Being Developed for High-Need Antimicrobial Infections
June 22, 2026 8:02 AM - PR NewsWire
Form 8-K Lakewood-Amedex Biothera For: Jun 15
June 17, 2026 11:41 AM - SEC Filing
Lakewood-Amedex Biotherapeutics to Present at Life Sciences Virtual Investor Forum
June 16, 2026 8:02 AM - PR NewsWire
Full Article List
